74 filings
15-12G
IMGO
Imago BioSciences, Inc.
23 Jan 23
Securities registration termination
7:25am
EFFECT
IMGO
Imago BioSciences, Inc.
17 Jan 23
Notice of effectiveness
12:15am
25-NSE
The Nasdaq Stock Market LLC
11 Jan 23
Exchange delisting
10:41am
S-8 POS
IMGO
Imago BioSciences, Inc.
11 Jan 23
Registration of securities for employees (post-effective amendment)
9:24am
S-8 POS
IMGO
Imago BioSciences, Inc.
11 Jan 23
Registration of securities for employees (post-effective amendment)
9:21am
POS AM
ygm 31fy3s
11 Jan 23
Prospectus update (post-effective amendment)
9:18am
8-K
suoyp90qz76w ijv
11 Jan 23
Completion of Acquisition or Disposition of Assets
9:00am
SC 14D9/A
n1wfcvc0i d1z
11 Jan 23
Tender offer solicitation (amended)
8:56am
SC TO-T/A
0yhgvy
11 Jan 23
Third party tender offer statement (amended)
8:50am
SC 14D9/A
a0bsz3qi 6xcptq4x
3 Jan 23
Tender offer solicitation (amended)
4:40pm
SC TO-T/A
c6b0ie3l
21 Dec 22
Third party tender offer statement (amended)
8:14am
SC 14D9/A
ytahoa
21 Dec 22
Tender offer solicitation (amended)
8:01am
8-K
3yavap6wape99
12 Dec 22
Imago BioSciences Presents Positive Data from Ongoing Phase 2 Study of Bomedemstat in Essential Thrombocythemia at ASH 2022
12:04pm
SC 14D9
1d26psmbaia
12 Dec 22
Tender offer solicitation
8:22am
SC TO-T
hqicds27
12 Dec 22
Third party tender offer statement
6:53am
SC14D9C
me059alydw1
21 Nov 22
Written communication relating to third party tender offer
5:23pm
SC TO-C
ht4w0x
21 Nov 22
Information about tender offer
9:15am
8-K
i82ynd n4wqjdl
21 Nov 22
Form of Tender and Support Agreement
7:03am
8-K
githhr5ov
9 Nov 22
Imago BioSciences Reports Third Quarter 2022 Financial
4:12pm